Juncture Wealth Strategies’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$929K Buy
11,865
+1,184
+11% +$80.7K 0.24% 67
2026
Q1
$690K Sell
10,681
-294
-3% -$20.7K 0.23% 65
2025
Q4
$739K Sell
10,975
-139
-1% -$9.35K 0.24% 58
2025
Q3
$815K Buy
11,114
+580
+6% +$38.5K 0.27% 53
2025
Q2
$548K Sell
10,534
-1,851
-15% -$105K 0.19% 64
2025
Q1
$790K Buy
12,385
+407
+3% +$23.6K 0.31% 56
2024
Q4
$573K Sell
11,978
-80
-0.7% -$4.1K 0.21% 65
2024
Q3
$690K Buy
12,058
+415
+4% +$23.8K 0.27% 60
2024
Q2
$610K Buy
11,643
+4,184
+56% +$183K 0.26% 55
2024
Q1
$303K Buy
+7,459
New +$280K 0.13% 86

Other funds holding HALO

Juncture Wealth Strategies's HALO Position: Q2 2026 in Review

Juncture Wealth Strategies increased its Halozyme (HALO) stake by 11% in Q2 2026, buying an estimated $80.7K and bringing the position to 11,865 shares worth $929K. The position accounts for 0.24% of the portfolio, ranked #67.

Juncture Wealth Strategies first reported a position in HALO in Q1 2024 and has held it in 10 quarters since. 342 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Juncture Wealth Strategies held 11,865 shares of Halozyme worth $929K as of Q2 2026.
  • Juncture Wealth Strategies bought 1,184 Halozyme shares in Q2 2026, an estimated $80.7K.
  • Halozyme made up 0.24% of Juncture Wealth Strategies's portfolio in Q2 2026, its #67 holding.
  • Juncture Wealth Strategies first reported a position in Halozyme in Q1 2024 and has held it in 10 quarters since.
  • 342 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Juncture Wealth Strategies's 13F filing for Q2 2026, filed 9 Jul 2026.